Drug Database
Back to search

Belgium· BE-AMP-SAM400662-00

Allegra Nasal 55 µg/dose

A triamcinolone product containing triamcinolone acetonide, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 11 of our 19 countries.

ATC R01AD11

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAllegra Nasal 55 µg/doseATCR01AD11REGISTER NO.BE-AMP-SAM400662-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about triamcinolone acetonideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Triamcinolone is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AD11 (triamcinolone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search triamcinolone products by name

Triamcinolone · ATC R01AD11

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Triamcinolone Acetonide
Manufacturer
Sanofi Belgium
Country
Belgium (BE)
ATC code
R01AD11
ATC class
Triamcinolone
Defined daily dose
0.22 mg, N
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3520673

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

38 interactions on record for triamcinolone.

Graded by severity as the source publishes them — 38 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check triamcinolone against other medicinesHow interaction checks work

Triamcinolone · interactions on record

38 records

  • 38 moderate

Most severe, free to view

  • MiconazoleA07AC01moderate
  • LonafarnibA16AX20moderate
  • VoxelotorB06AX03moderate
  • ConivaptanC03XA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Triamcinolone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triamcinolone products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Volon, Volon A
  • Cyprus · Triacort
  • Czechia · Triamcinolon Léčiva
  • Germany · Nasacort, Rhinisan
  • Denmark · Kenalog, Triamcinolone Acetonide Medipha
  • Estonia · Kenalog
  • Spain · Nasacort
  • Finland · Nasacort, Triamcinolone Medipha
  • France · Kenacort Retard, Nasacort
  • United Kingdom (Northern Ireland) · Nasacort
  • Greece · Jiven, Nasacort
  • Croatia · Kenalog
  • Hungary · Ftorocort, Kenalog
  • Ireland · Nasacort, Nasacort Allergy
  • Iceland · Kenacort-T, Nasacort
  • Italy · Kenacort, Nasacort
  • Lithuania · Ftorocort, Kenalog
  • Luxembourg · Delphi, Kenacort-A
  • Latvia · Ftorocort, Kenalog
  • Malta · Nasacort, Nasacort Allergy
  • Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
  • Norway · Kenacort-T, Nasacort
  • Poland · Polcortolon
  • Portugal · Nasacort, Telfast Spray Nasal
  • Sweden · Kenacort-T, Nasacort
  • Slovenia · Kenalog
  • Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4760c143-ded0-4911-ad3d-1b05d0d27a89
GET /v1/drugs/4760c143-ded0-4911-ad3d-1b05d0d27a89?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, suspension",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Allegra Nasal 55 µg/dose",
  "name_fr": "Allegra Nasal 55 µg/dose",
  "name_nl": "Allegra Nasal 55 µg/dose",
  "amp_code": "SAM400662-00",
  "strengths": [
    "55.0000",
    "55.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Triamcinolone Acetonide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Triamcinolone",
  "authorisation_numbers": [
    "BE400662",
    "BE400671"
  ]
}
API referenceMCP serverPlans

See everything about triamcinolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console